SHANNA SUDERMAN: Open Payments
NPI 1588704076 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,694 in 158 payments from 16 companies in 2025. Trend: 2023 $2,313 · 2024 $3,073 · 2025 $2,694
Food & beverage: $2,592Education: $102
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 32 | $674 |
| ABBVIE INC. | 38 | $557 |
| Novartis Pharmaceuticals Corporation | 22 | $336 |
| Lilly USA, LLC | 10 | $219 |
| E.R. Squibb & Sons, L.L.C. | 19 | $213 |
| Regeneron Healthcare Solutions, Inc. | 11 | $210 |
| GENZYME CORPORATION | 6 | $138 |
| LEO Pharma Inc. | 4 | $84 |
| Galderma Laboratories, L.P. | 4 | $67 |
| UCB, Inc. | 3 | $53 |
Products named: TREMFYA, COSENTYX, DUPIXENT, RINVOQ, SKYRIZI, Sotyktu, EBGLYSS, TALTZ.
Industry payments across KS — which companies pay providers there.
